Efecto del ácido cítrico sobre los compuestos fenólicos, los flavonoides y la capacidad antioxidante en brotes de trigo

Wheat sprouts are a source of carbohydrates, fiber, vitamins, essential nutrients and bioactive compounds that have been linked to the prevention and treatment of illnesses. The presence of these compounds in wheat sprouts may be increased by means of the application of organic acids during the growth stage. The objective of this investigation was to evaluate the effect of a sprayed application of citric acid (0, 10-2, 10-3, 10-4 and 10-5 M) on the total antioxidant capacity and total content of phenolic compounds and flavonoids in wheat sprouts. A completely randomized design was used, consisting of six repetitions. The results showed that phenolic compounds, flavonoids and antioxidant capacity increased significantly with the application of a 10-2 M foliar spray as compared to the control. As such, the spraying of low concentrations of secondary metabolism-inducing molecules during the sprout development process is a useful and effective method to stimulate the biosynthesis of bioactive phytochemicals and improve the nutraceutical quality of wheat sprouts.Los brotes o germinados son una fuente de carbohidratos, fibra, vitaminas, nutrimentos esenciales y compuestos bioactivos, los cuales se han relacionado con la prevención y tratamiento de enfermedades. La presencia de estos compuestos, en brotes de trigo, pueden incrementarse mediante la aplicación de ácidos orgánicos durante la etapa de crecimiento. El objetivo de la presente investigación fue evaluar el efecto de la aplicación por aspersión de ácido cítrico (0, 10-2, 10-3, 10-4 y 10-5 M) en la capacidad antioxidante total, contenido de compuestos fenólicos totales y flavonoides totales en brotes de trigo. Se utilizó un diseño completamente al azar con seis repeticiones. Los resultados mostraron que los compuestos fenólicos, flavonoides y la capacidad antioxidante se incrementaron significativamente con la aspersión foliar 10-2 M en relación al testigo. Por lo tanto, la aspersión de bajas concentraciones de moléculas inductoras del metabolismo secundario durante la etapa de desarrollo de brotes es un método útil y efectivo para estimular la biosíntesis de fitoquímicos bioactivos y mejorar calidad nutracéutica de los brotes de trigo.Fil: Preciado-Rangel, Pablo. Instituto Tecnológico de Torreón (México)Fil: Gaucín-Delgado, Jazmín Monserrat. Instituto Tecnológico de Torreón (México)Fil: Salas-Pérez, Lilia. Universidad Politécnica de Gómez Palacio (México)Fil: Sánchez Chavez, Esteban. Centro de Investigación en Alimentación y Desarrollo (México)Fil: Mendoza-Vllarreal, Rosalinda. Universidad Autónoma Agraria Antonio Narro (México)Fil: Rodríguez Ortiz, Juan Carlos. Universidad Autónoma de San Luis Potosí (México

Agronomic biofortification with selenium improves the yield and nutraceutical quality in tomato under soilless conditions

Selenium (Se) is an essential element for humans. Its consumption comes from food of animal or vegetal origin; whose content varies widely depending on its availability in soil or anthropogenic sources. Biofortification improves food nutritional quality, and its consumption has a positive influence in human health. Thus, the objective of this research was to assess agricultural biofortification with Se in tomato fruit and its effects on yield, nutraceutical quality, and antioxidant capacity.  Five Se doses (0, 2, 4, 6, and 8 mg L-1) in the form of sodium selenite (Na2SeO3) were added in a nutritional solution in a hydroponic system.  The results obtained indicated that agricultural biofortification with Se applied in the nutritional solution improved yield, nutraceutical quality, and Se concentration in tomato fruit. The optimum Se dose that maximized yield and nutraceutical quality, as well as the recommended consumption concentration in tomato fruit in this study was 2 mg L-1 (Na2SeO4) because higher doses decreased yield and bioactive compound biosynthesis. Incorporating Se in the nutritional solution is an alternative to increase phytochemical compound biosynthesis in tomato fruit and yield with the possibility of improving public health with its consumption

Measurement of the cosmic ray spectrum above 4×10184{\times}10^{18} eV using inclined events detected with the Pierre Auger Observatory

A measurement of the cosmic-ray spectrum for energies exceeding $4{\times}10^{18}$ eV is presented, which is based on the analysis of showers with zenith angles greater than $60^{\circ}$ detected with the Pierre Auger Observatory between 1 January 2004 and 31 December 2013. The measured spectrum confirms a flux suppression at the highest energies. Above $5.3{\times}10^{18}$ eV, the "ankle", the flux can be described by a power law $E^{-\gamma}$ with index $\gamma=2.70 \pm 0.02 \,\text{(stat)} \pm 0.1\,\text{(sys)}$ followed by a smooth suppression region. For the energy ($E_\text{s}$) at which the spectral flux has fallen to one-half of its extrapolated value in the absence of suppression, we find $E_\text{s}=(5.12\pm0.25\,\text{(stat)}^{+1.0}_{-1.2}\,\text{(sys)}){\times}10^{19}$ eV.Comment: Replaced with published version. Added journal reference and DO

Energy Estimation of Cosmic Rays with the Engineering Radio Array of the Pierre Auger Observatory

The Auger Engineering Radio Array (AERA) is part of the Pierre Auger Observatory and is used to detect the radio emission of cosmic-ray air showers. These observations are compared to the data of the surface detector stations of the Observatory, which provide well-calibrated information on the cosmic-ray energies and arrival directions. The response of the radio stations in the 30 to 80 MHz regime has been thoroughly calibrated to enable the reconstruction of the incoming electric field. For the latter, the energy deposit per area is determined from the radio pulses at each observer position and is interpolated using a two-dimensional function that takes into account signal asymmetries due to interference between the geomagnetic and charge-excess emission components. The spatial integral over the signal distribution gives a direct measurement of the energy transferred from the primary cosmic ray into radio emission in the AERA frequency range. We measure 15.8 MeV of radiation energy for a 1 EeV air shower arriving perpendicularly to the geomagnetic field. This radiation energy -- corrected for geometrical effects -- is used as a cosmic-ray energy estimator. Performing an absolute energy calibration against the surface-detector information, we observe that this radio-energy estimator scales quadratically with the cosmic-ray energy as expected for coherent emission. We find an energy resolution of the radio reconstruction of 22% for the data set and 17% for a high-quality subset containing only events with at least five radio stations with signal.Comment: Replaced with published version. Added journal reference and DO

Measurement of the Radiation Energy in the Radio Signal of Extensive Air Showers as a Universal Estimator of Cosmic-Ray Energy

We measure the energy emitted by extensive air showers in the form of radio emission in the frequency range from 30 to 80 MHz. Exploiting the accurate energy scale of the Pierre Auger Observatory, we obtain a radiation energy of 15.8 \pm 0.7 (stat) \pm 6.7 (sys) MeV for cosmic rays with an energy of 1 EeV arriving perpendicularly to a geomagnetic field of 0.24 G, scaling quadratically with the cosmic-ray energy. A comparison with predictions from state-of-the-art first-principle calculations shows agreement with our measurement. The radiation energy provides direct access to the calorimetric energy in the electromagnetic cascade of extensive air showers. Comparison with our result thus allows the direct calibration of any cosmic-ray radio detector against the well-established energy scale of the Pierre Auger Observatory.Comment: Replaced with published version. Added journal reference and DOI. Supplemental material in the ancillary file

Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients with type 2 diabetes. METHODS In this double-blind, randomized trial, we assigned patients with type 2 diabetes and albuminuric chronic kidney disease to receive canagliflozin, an oral SGLT2 inhibitor, at a dose of 100 mg daily or placebo. All the patients had an estimated glomerular filtration rate (GFR) of 30 to <90 ml per minute per 1.73 m2 of body-surface area and albuminuria (ratio of albumin [mg] to creatinine [g], >300 to 5000) and were treated with renin–angiotensin system blockade. The primary outcome was a composite of end-stage kidney disease (dialysis, transplantation, or a sustained estimated GFR of <15 ml per minute per 1.73 m2), a doubling of the serum creatinine level, or death from renal or cardiovascular causes. Prespecified secondary outcomes were tested hierarchically. RESULTS The trial was stopped early after a planned interim analysis on the recommendation of the data and safety monitoring committee. At that time, 4401 patients had undergone randomization, with a median follow-up of 2.62 years. The relative risk of the primary outcome was 30% lower in the canagliflozin group than in the placebo group, with event rates of 43.2 and 61.2 per 1000 patient-years, respectively (hazard ratio, 0.70; 95% confidence interval [CI], 0.59 to 0.82; P=0.00001). The relative risk of the renal-specific composite of end-stage kidney disease, a doubling of the creatinine level, or death from renal causes was lower by 34% (hazard ratio, 0.66; 95% CI, 0.53 to 0.81; P<0.001), and the relative risk of end-stage kidney disease was lower by 32% (hazard ratio, 0.68; 95% CI, 0.54 to 0.86; P=0.002). The canagliflozin group also had a lower risk of cardiovascular death, myocardial infarction, or stroke (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P=0.01) and hospitalization for heart failure (hazard ratio, 0.61; 95% CI, 0.47 to 0.80; P<0.001). There were no significant differences in rates of amputation or fracture. CONCLUSIONS In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a median follow-up of 2.62 years